Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway

被引:22
|
作者
Liu, Xia [1 ]
Peng, Jiamin [2 ]
Zhou, Yayun [2 ]
Xie, Bei [2 ]
Wang, Jianchao [3 ]
机构
[1] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Cent Lab, 318 C haowang Rd, Hangzhou 310005, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou 310005, Zhejiang, Peoples R China
[3] Zhejiang Tongde Hosp Zhejiang Prov, Dept Clin Lab, 234 Gucui Rd, Hangzhou 310012, Zhejiang, Peoples R China
关键词
multiple myeloma; ribonucleotide reductase M2; DNA damage; apoptosis; Wnt/beta-catenin signaling; RIBONUCLEOTIDE REDUCTASE M2; THERAPEUTIC TARGET; RNA INTERFERENCE; CANCER; SUBUNIT; EXPRESSION; CELLS; SUPPRESSION; APOPTOSIS; PROMOTES;
D O I
10.3892/mmr.2019.10465
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ribonucleotide reductase M2 (RRM2) is one of the two subunits that comprise ribonucleotide reductase (RR), the enzyme that catalyzes the conversion of ribonucleotide 5'-diphosphates into 2'-deoxyribonucleotides, which are required for DNA synthesis. RRM2 is a stress response factor important for the development of several tumors. However, its role in multiple myeloma (MM) remains to be fully elucidated. The present study aimed to investigate the role of RRM2 in MM. The expression of RRM2 in patients with MM was analyzed using the Oncomine database. The results demonstrated that RRM2 expression was higher in MM compared with healthy subjects. Reverse transcription-quantitative polymerase chain reaction and western blot results revealed that RRM2 expression was decreased following transfection with a small interfering RNA targeting RRM2 into NCI-H929 cells. RR activity and Cell Counting Kit-8 assays demonstrated that RRM2 silencing reduced RR activity and inhibited cell proliferation. Annexin V-propidium iodide staining indicated that the percentage of apoptotic NCI-H929 cells was increased following RRM2 silencing compared with that in the control group. Increased phosphorylation of H2AX indicated that RRM2 silencing may activate the DNA-damage response pathway in NCI-H929 cells. Western blot analysis revealed that protein levels of the apoptosis-associated factor Bcl-2 were reduced, whereas Bax, cleaved caspase-3 and cleaved poly(ADP-ribose) polymerase 1 were upregulated following RRM2 silencing compared with the control group. In addition, the results demonstrated that RRM2 silencing may inhibit target gene expression in the Wnt/beta-catenin signaling pathway by increasing the phosphorylation of glucose synthase kinase 3 beta. These findings indicated that RRM2 may be involved in the proliferation and apoptosis of MM cells via the Wnt/beta-catenin signaling pathway, suggesting that RRM2 may represent a novel therapeutic target for MM.
引用
收藏
页码:2159 / 2166
页数:8
相关论文
共 50 条
  • [41] Activation of the Wnt/β-Catenin Pathway Mediates Lenalidomide Resistance in Multiple Myeloma
    Bjorklund, Chad C.
    Kuhn, Deborah J.
    Matthews, Jairo A.
    Wang, Michael
    Baladandayuthapani, Veerabhadran
    Orlowski, Robert Z.
    BLOOD, 2009, 114 (22) : 51 - 52
  • [42] Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
    Cheng, Xiaofei
    Xu, Xiangming
    Chen, Dong
    Zhao, Feng
    Wang, Weilin
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 473 - 481
  • [43] Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives
    Wang, Zhen
    Li, Zilu
    Ji, Haitao
    MEDICINAL RESEARCH REVIEWS, 2021, 41 (04) : 2109 - 2129
  • [44] Targeting RRM2 by triapine sensitizes glioblastoma to radiotherapy
    Corrales-Guerrero, Sergio
    Bell, Erica H.
    Chakravarti, Arnab
    Shen, Changxian
    Williams, Terence M.
    CANCER RESEARCH, 2020, 80 (16)
  • [45] Advances in targeting the WNT/13-catenin signaling pathway in cancer
    Chatterjee, Avradip
    Paul, Sayan
    Bisht, Bharti
    Bhattacharya, Shelley
    Sivasubramaniam, Sudhakar
    Paul, Manash K.
    DRUG DISCOVERY TODAY, 2022, 27 (01) : 82 - 101
  • [46] Nitazoxanide and Cancer Drug Resistance: Targeting Wnt/β-catenin Signaling Pathway
    Hemmati-Dinarvand, Mohsen
    Ahmadvand, Hassan
    Seghatoleslam, Atefeh
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (03) : 263 - 270
  • [47] Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
    Xueping Jiang
    Yangyi Li
    Nannan Zhang
    Yanping Gao
    Linzhi Han
    Shuying Li
    Jiali Li
    Xingyu Liu
    Yan Gong
    Conghua Xie
    Cell & Bioscience, 12
  • [48] FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway
    Chen, Yanyan
    Rao, Xianping
    Huang, Kangmao
    Jiang, Xiaoxia
    Wang, Haohao
    Teng, Lisong
    JOURNAL OF CANCER, 2017, 8 (16): : 3142 - 3153
  • [49] Autophagy and the Wnt signaling pathway: A focus on Wnt/β-catenin signaling
    Lorzadeh, Shahrokh
    Kohan, Leila
    Ghavami, Saeid
    Azarpira, Negar
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (03):
  • [50] Capsaicin inhibits the Wnt/β-catenin signaling pathway by down-regulating PP2A
    Park, Dong-Seok
    Yoon, Gang-Ho
    Lee, Hyun-Shik
    Choi, Sun-Cheol
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (01) : 455 - 461